Cross Country Healthcare Files Reg FD Disclosure on Feb 1, 2024

TL;DR

**CCRN just dropped a Reg FD 8-K, signaling important news is out for everyone.**

AI Summary

Cross Country Healthcare, Inc. filed an 8-K on February 1, 2024, under Regulation FD Disclosure. This filing indicates that the company is making a public disclosure of material non-public information, likely to ensure fair and broad dissemination to all investors simultaneously. For stockholders, this means the company is proactively sharing important news, which could impact their investment decisions, rather than allowing information to leak or be selectively disclosed.

Why It Matters

This filing ensures all investors receive material information at the same time, preventing unfair advantages and promoting transparency in the market for CCRN stock.

Risk Assessment

Risk Level: low — A Regulation FD disclosure itself is a procedural filing to ensure fair information dissemination, not an inherently risky event.

Analyst Insight

A smart investor would look for a subsequent press release or investor presentation from Cross Country Healthcare, Inc. that explains the specific material information being disclosed under Regulation FD, as this 8-K only signals that such information has been or will be released.

Key Players & Entities

• Cross Country Healthcare, Inc. (company) — the registrant filing the 8-K
• February 1, 2024 (date) — date of earliest event reported and filing date
• Nasdaq Stock Market LLC (company) — exchange where CCRN common stock is registered
• $0.0001 (dollar_amount) — par value per share of common stock

FAQ

Key Financial Figures

• $0.0001 — ich registered Common stock, par value $0.0001 per share CCRN The Nasdaq Stock Market

Filing Documents

• ccrn-20240201.htm (8-K) — 29KB
• ccrn20240201-earningscalle.htm (EX-99.1) — 6KB
• ccrn-20240201_g1.jpg (GRAPHIC) — 81KB
• 0001628280-24-002913.txt ( ) — 369KB
• ccrn-20240201.xsd (EX-101.SCH) — 2KB
• ccrn-20240201_lab.xml (EX-101.LAB) — 23KB
• ccrn-20240201_pre.xml (EX-101.PRE) — 12KB
• ccrn-20240201_htm.xml (XML) — 3KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On February 1, 2024, the Company issued a press release, a copy of which is furnished herewith as Exhibit 99.1. Pursuant to General Instruction B.2 of Current Report on Form 8-K, the information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of such section. Furthermore, the information in this Item 7.01, including Exhibit 99.1, shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Exchange Act, regardless of the general incorporation language of such filing, except as shall be expressly set forth by specific reference in such filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit Description 99. 1 Press Release issued by the Company on February 1, 2024 104.1 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. CROSS COUNTRY HEALTHCARE, INC. Dated: February 1, 2024 By: /s/ William J. Burns Name: William J. Burns Title: Executive Vice President & Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR